Non-Ischemic Central Retinal Vein Occlusion
1 clinical trials · Condition
◉ Watch Non-Ischemic Central Retinal Vein Occlusion
| Record | Firm | Date |
|---|---|---|
| Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion (NCT01295112) | Texas Retina Associates | 2011-05-01 |
Track Non-Ischemic Central Retinal Vein Occlusion automatically
Every clearance here is in the API, with alerts when new ones post.